Curcumin and saroglitazar attenuate diet-induced nonalcoholic steatohepatitis by activating the Nrf2 pathway and suppressing ERK1/2 signaling. This evidence concerns the gene MAPK3 and metabolic dysfunction-associated steatohepatitis.